Age Above 60 Years Is Not a Negative Predictive Factor For Combined Antiviral Therapy With Pegylated Interferon Alpha and Ribavirin in Hepatitis C Patients

Frei, P; Leucht, AK; Held, U; Kofmehl, R; Schmitt, J; Rau, M; Gerlach, T; Negro, F; Heim, MH; Moradpour, D; Cerny, A; Dufour, Jean-François; Mullhaupt, B; Geier, A (2011). Age Above 60 Years Is Not a Negative Predictive Factor For Combined Antiviral Therapy With Pegylated Interferon Alpha and Ribavirin in Hepatitis C Patients. Hepatology, 54(1), 826A-826A. Hoboken, N.J.: Wiley Interscience

Full text not available from this repository. (Request a copy)

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Visceral Surgery and Medicine > Hepatology
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Hepatologie
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Hepatologie

UniBE Contributor:

Dufour, Jean-François

ISSN:

0270-9139

Publisher:

Wiley Interscience

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:23

Last Modified:

10 Oct 2016 19:49

Web of Science ID:

000295578003212

URI:

https://boris.unibe.ch/id/eprint/8045 (FactScience: 213481)

Actions (login required)

Edit item Edit item
Provide Feedback